Akiko Enomoto

1.2k citations
28 papers · 937 indexed · h-index 14
Topics
Bioactive Compounds and Antitumor Agents (2 papers)Microbial Natural Products and Biosynthesis (2 papers)Peroxisome Proliferator-Activated Receptors (2 papers)

In The Last Decade

Akiko Enomoto

28 papers receiving 902 citations

Peers

Akiko Enomoto
Comparison fields: 5 of 103
  • Molecular Biology 439
  • Immunology 181
  • Oncology 129
  • Organic Chemistry 101
  • Cancer Research 98
Replace Pei Xiao with:
Pei Xiao China
Xiuwei Tang United States
M. Noshiro Japan
Roberto Campagna Italy
Yasuko Koshihara Japan
Hong Huang China
Margarita Mikhailova United States
Gaurav Swarnkar United States
Meichun Hu China
Dae-won Jeong South Korea
Akiko Enomoto relative to Pei Xiao China Pei Xiao's profile →
Citations per field
00.5×6.7×
Pei Xiao · 1×
Citations per year

Countries citing papers authored by Akiko Enomoto

Since Specialization
Citations

This map shows the geographic impact of Akiko Enomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Enomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Enomoto more than expected).

Fields of papers citing papers by Akiko Enomoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Enomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Enomoto. The network helps show where Akiko Enomoto may publish in the future.

Co-authorship network of co-authors of Akiko Enomoto

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Enomoto. A scholar is included among the top collaborators of Akiko Enomoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Enomoto. Akiko Enomoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 11
4 13
5 32
6 12
7 7
8 3
9 45
10 34
11 4
12 75
13 25
14 299
15 31
16 61
17 3
18 4
19 36
20 4

About Akiko Enomoto

Akiko Enomoto is a scholar working on Toxicology, Complementary and Manual Therapy and Oral Surgery, having authored 28 papers that have together received 937 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Oral Surgery (85 citations), Urology (58 citations) and Immunology (181 citations). Akiko Enomoto has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Kanki Komiyama, Masahiko Hayashi, Aki Hirayama, Ken Itoh, Satoru Takahashi, Naoto Yamaguchi, Naoki Morito, Akio Kôyama, Masayuki Yamamoto and Keigyou Yoh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026